This product is currently out of stock and unavailable.

SKU: N/A Category:

Global Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market Outlook: 2013-2018

  • Sep, 2013
  • pages: 270
  • formats:* PDF
  • Report ID: MRPH-10401

Product Description

Radiopharmacology is the study and preparation of radiopharmaceuticals, which are radioactive pharmaceuticals. Radiopharmaceuticals are used in the field of nuclear medicine as tracers in the diagnosis and treatment of many diseases. Utilization of these molecules for medical purposes in PET and SPECT imaging has changed the entire algorithm of disease diagnosis. With rise in the aging population globally coupled with increasing rate of chronic cardiovascular, oncology and neurology diseases, there is tremendous growth potential in this market, especially in developing nations.
The major driving forces of radiopharmaceuticals market are increasing incidence of cancer and cardiac ailments, increasing use of SPECT and PET scans, rising awareness of radiopharmaceuticals, and ready availability of radiopharmaceuticals from cyclotrons. However, shorter half-life of radiopharmaceuticals and competition from conventional diagnostic procedures are restraints of the market.
The Radiopharmacology market is broadly segmented as diagnostic and therapeutic. Diagnostic market is further classified as SPECT and PET, followed by Thallium-201(Tl-201), Gallium-67 (Ga-67) and Iodine-123 (I-123). SPECT is majorly used in cardiology related diagnosis. The PET radioisotopes market is dominated by Fluoride-18 (F-18), followed by Rubidium-82 (Rb-82), While Therapeutic market is further classified into beta emitters, brachytherapy isotopes, and alpha emitters.
This research report provides comprehensive analysis of radiopharmaceutical market across the globe. The geographical regions covered in this report are North America (U.S, Canada), Europe (Germany, France, Italy, U.K, Spain), Asia- pacific (Japan, India, Chain) and rest of world (Latin America, Middle East Africa).
The research report meticulously analyses the radiopharmaceutical market on the basis of following categories.
Radiopharmaceuticals Market
 Tc-99m
 Tl-201
 Ga-67
 I-123
 Others
 F-18
 Rb-82
 Others
• Therapy
o Beta emitters
 I-131
 Sm-153
 Re-186
 Y-90
 Lu-177
 Others
o Alpha emitters
o Brachytherapy
 Cs-131
 I-125
 Pd-103
 Ir-192
 Others
Enriched Stable Isotopes Market
• Deuterium
• Oxygen-18
• Carbon-13
• Nitrogen-15
• Others
Source: Expert Interviews, Government Authorities, Related associations/Institutes, Related Research Publication, Government Publication, Company Press Release, Company Annual Reports, Company Website, Company Publication, SEC Filings, Meticulous Analysis.


For Detailed Table Of Content, Please




Download Sample

Please fill in the form below to receive the free sample pages of the report.


Need Customization?

Not satisfied with the defined report scope. No worries, we can customize this report for you.
Please fill in the form below and our research analyst will get in touch with you immediately.


There are no reviews yet.

Be the first to review “Global Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market Outlook: 2013-2018”

Your email address will not be published. Required fields are marked *